At a glance
- Originator Cryopharm
- Class Antivirals; Benzopyrans
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 03 Dec 2004 Discontinued - Preclinical for HIV-1 infections in USA (unspecified route)
- 18 May 2001 Profile reviewed but no significant changes made
- 30 Jul 1998 No-Development-Reported for HIV-1 infections in USA (Unknown route)